China · Delayed Price · Currency is CNY Bright Eye Hospital Group Statistics
Total Valuation
SHE:301239 has a market cap or net worth of CNY 5.12 billion. The enterprise value is 6.58 billion.
| Market Cap | 5.12B |
| Enterprise Value | 6.58B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Sep 11, 2026 |
Share Statistics
SHE:301239 has 148.86 million shares outstanding. The number of shares has decreased by -1.14% in one year.
| Current Share Class | 148.86M |
| Shares Outstanding | 148.86M |
| Shares Change (YoY) | -1.14% |
| Shares Change (QoQ) | +1.12% |
| Owned by Insiders (%) | 42.88% |
| Owned by Institutions (%) | 14.13% |
| Float | 77.85M |
Valuation Ratios
The trailing PE ratio is 70.14.
| PE Ratio | 70.14 |
| Forward PE | n/a |
| PS Ratio | 1.68 |
| PB Ratio | 2.35 |
| P/TBV Ratio | 3.32 |
| P/FCF Ratio | 12.72 |
| P/OCF Ratio | 7.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.12, with an EV/FCF ratio of 16.33.
| EV / Earnings | 89.14 |
| EV / Sales | 2.16 |
| EV / EBITDA | 9.12 |
| EV / EBIT | 24.04 |
| EV / FCF | 16.33 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.91.
| Current Ratio | 0.98 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 2.74 |
| Debt / FCF | 4.91 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.87% and return on invested capital (ROIC) is 4.05%.
| Return on Equity (ROE) | 3.87% |
| Return on Assets (ROA) | 3.66% |
| Return on Invested Capital (ROIC) | 4.05% |
| Return on Capital Employed (ROCE) | 7.38% |
| Weighted Average Cost of Capital (WACC) | 5.65% |
| Revenue Per Employee | 606,348 |
| Profits Per Employee | 14,705 |
| Employee Count | 5,018 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 8.45 |
Taxes
In the past 12 months, SHE:301239 has paid 71.63 million in taxes.
| Income Tax | 71.63M |
| Effective Tax Rate | 46.17% |
Stock Price Statistics
The stock price has decreased by -8.58% in the last 52 weeks. The beta is 0.65, so SHE:301239's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -8.58% |
| 50-Day Moving Average | 33.42 |
| 200-Day Moving Average | 34.75 |
| Relative Strength Index (RSI) | 54.40 |
| Average Volume (20 Days) | 3,435,972 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301239 had revenue of CNY 3.04 billion and earned 73.79 million in profits. Earnings per share was 0.49.
| Revenue | 3.04B |
| Gross Profit | 1.29B |
| Operating Income | 273.63M |
| Pretax Income | 155.15M |
| Net Income | 73.79M |
| EBITDA | 430.36M |
| EBIT | 273.63M |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 552.91 million in cash and 1.98 billion in debt, with a net cash position of -1.42 billion or -9.56 per share.
| Cash & Cash Equivalents | 552.91M |
| Total Debt | 1.98B |
| Net Cash | -1.42B |
| Net Cash Per Share | -9.56 |
| Equity (Book Value) | 2.18B |
| Book Value Per Share | 14.32 |
| Working Capital | -17.20M |
Cash Flow
In the last 12 months, operating cash flow was 670.51 million and capital expenditures -267.83 million, giving a free cash flow of 402.68 million.
| Operating Cash Flow | 670.51M |
| Capital Expenditures | -267.83M |
| Depreciation & Amortization | 156.73M |
| Net Borrowing | -97.43M |
| Free Cash Flow | 402.68M |
| FCF Per Share | 2.71 |
Margins
Gross margin is 42.41%, with operating and profit margins of 8.99% and 2.43%.
| Gross Margin | 42.41% |
| Operating Margin | 8.99% |
| Pretax Margin | 5.10% |
| Profit Margin | 2.43% |
| EBITDA Margin | 14.14% |
| EBIT Margin | 8.99% |
| FCF Margin | 13.23% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 73.22% |
| FCF Payout Ratio | 11.09% |
| Buyback Yield | 1.14% |
| Shareholder Yield | 2.88% |
| Earnings Yield | 1.43% |
| FCF Yield | 7.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |